Page last updated: 2024-08-17

levodopa and Depressive Disorder

levodopa has been researched along with Depressive Disorder in 81 studies

Research

Studies (81)

TimeframeStudies, this research(%)All Research%
pre-199027 (33.33)18.7374
1990's23 (28.40)18.2507
2000's18 (22.22)29.6817
2010's13 (16.05)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bichon, A; Broussolle, E; Carnicella, S; Castrioto, A; Delpont, B; Fraix, V; Kistner, A; Klinger, H; Krack, P; Lhommée, E; Lüscher, C; Pélissier, P; Pollak, P; Quesada, JL; Schmitt, E; Thobois, S1
Cao, B; Chen, Y; Hou, Y; Liu, H; Ou, R; Shang, H; Song, W; Wei, Q; Yuan, X; Zhang, L1
Akyildiz, U; Akyol, A; Dogan, B; Memis, CO; Sair, A; Sevincok, L1
Chen, S; Cui, S; Du, JJ; Fu, R; Gao, C; Huang, P; Lin, Y; Wang, T; Zhou, H1
Eggers, C; Horstkoetter, N; Kalbe, E; Kuhn, J; Lewis, CJ; Maarouf, M; Maier, F; Moro, E; Timmermann, L; Woopen, C; Zurowski, M1
Baybas, S; Dirican, A; Dogan, GB; Dogan, VB; Koksal, A1
Bingefors, K; Isacson, D; Kristiansen, IS; Nyholm, D1
García-Sánchez, C; Gironell, A; Kulisevsky, J; Martínez-Corral, M; Pagonabarraga, J; Pascual-Sedano, B1
Kulisevsky, J; Martinez-Corral, M; Pagonabarraga, J1
Chan, P; Fang, X; Liu, H; Qin, Z; Sun, F; Zhang, L1
Adam, OR; Ferrara, JM; Ondo, WG1
Dale, RC; Earl, J; Fung, VS; Grattan-Smith, P; Houlden, H; Melchers, A1
Amthauer, H; Assion, HJ; Beucke, JC; Endrass, T; Juckel, G; Kupsch, A; Plotkin, M; Uhl, I; Winter, C1
Bugalho, P; Cargaleiro, I; da Silva, JA; Neto, B; Serra, M1
Bloem, BR; Munneke, M; Petzinger, GM; Speelman, AD; van de Warrenburg, BP; van Nimwegen, M1
Antonini, A; Biundo, R; D'Avella, D; Ferla, S; Landi, A; Padoan, A; Pilleri, M1
Artigas, CF; Espino Ibáñez, A; Masmiquel Comas, L; Nicolau Ramis, J; Rivera Irigoín, R1
Bagheri, H; Montastruc, JL; Schmitt, L1
Jähnel, M1
Ishizu, H; Kuroda, S; Terada, S1
Allen, RC; Bakay, RA; Cornfeldt, ML; Raiser, CD; Schweikert, AW; Stover, NP; Subramanian, T; Watts, RL1
Duda, JE; Moberg, PJ; Morales, KH; Stern, MB; Weintraub, D1
Ardouin, C; Batir, A; Benabid, AL; Chabardès, S; Cools, R; Fraix, V; Funkiewiez, A; Krack, P; Pollak, P; Robbins, TW1
Bernardi, S; Meco, G1
Daniels, C; Deuschl, G; Herzog, J; Krack, P; Lorenz, D; Mehdorn, M; Reiff, J; Volkmann, J; Witt, K1
Alicock, LM1
Marinus, J; van Hilten, JJ; van Rooden, SM; Verbaan, D; Visser, M1
de Haan, RJ; Post, B; Speelman, JD1
Bria, P; Dario, T; Frustaci, A; Janiri, L; Martinotti, G; Pozzi, G; Reina, D1
Bitton, V; Melamed, E1
Linkowski, P; Mendlewicz, J1
Cooper, BR; Howard, JL; Soroko, FE1
Narabayashi, H1
Brauman, H; Linkowski, P; Mendlewicz, J1
Côté, L; Mayeux, R; Stern, Y; Williams, JB1
Coignet, A; de Recondo, J; Rondot, P; Ziegler, M1
Boni, B; Casacchia, M; Meco, G1
Klawans, HL1
Berezhnaia, VA; Nuller, IuL; Ostroumova, MN1
Calabrese, P; Durwen, HF; Gehlen, W; Holinka, B; Markowitsch, HJ1
Huszonek, JJ1
Caparros-Lefebvre, D; Duhamel, A; Pécheux, N; Petit, H; Petit, V1
Kathol, RG; Long, TD1
Jeanneau, A; Olie, JP1
Agren, H; Reibring, L1
Baas, H; Fischer, PA; Stecker, K1
Hesselink, JM1
Bowes, SG; Charlett, A; Dickins, J; Dobbs, RJ; Dobbs, SM; Frith, C; Henley, M1
López de Munain, A; Martí Massó, JF; Poza, JJ1
Simpson, JS1
Bowers, MB1
Nakajima, T1
Dobato, JL; Giménez-Roldán, S; Mateo, D1
Berger, M; Frauenknecht, S; Hesslinger, B; Normann, C; Walden, J1
Choi, C; Kim, J; Lee, JH; Sohn, YH1
Masson, C1
Linkowski, P; Mendlewicz, J; Van Cauter, E1
Brusov, OS; Lideman, RR1
Ashford, JW; Hargrave, R1
Manji, HK; Potter, WZ; Rudorfer, MV1
Bordet, R; Destée, A1
Cutlip, WD; Makela, EH1
Kuhn, W; Przuntek, H1
Garfinkel, BD; Jensen, JB1
Meltzer, HY; Parsa, MA; Ramirez, LF; Rohr, T1
Byerley, WF; Risch, SC1
Cote, L; Dyrenfurth, I; Frantz, A; Mayeux, R; Stern, Y; Williams, JB1
Arikawa, K; Inanaga, K; Kuniyoshi, M; Miura, C1
Douyon, R; Klutchko, B; Rotrosen, J; Serby, M1
Yu, PH1
Fahn, S1
Schnaberth, G1
Johansson, F; von Knorring, L1
Cummings, JL; Friedenberg, DL1
Birkmayer, W1
Battegay, R; Gastpar, M; Zmilacher, K1
Brown, RG; Gotham, AM; Marsden, CD; Nissenbaum, H; Quinn, NP; Toone, B1
Harvey, NS1
el-Awar, M; Freedman, M; Goldenberg, L; Little, J; Seeman, P; Solomon, P1
Cheng, SC; Diercks, MJ; Glaeske, C; Hsieh, HH; Jefferson, A; Pfeiffer, RF1
Jaeckle, RS; Nasrallah, HA1

Reviews

13 review(s) available for levodopa and Depressive Disorder

ArticleYear
How might physical activity benefit patients with Parkinson disease?
    Nature reviews. Neurology, 2011, Jul-12, Volume: 7, Issue:9

    Topics: Antiparkinson Agents; Cardiovascular Diseases; Cognition; Constipation; Depressive Disorder; Dopamine; Humans; Levodopa; Motor Activity; Muscle Fatigue; Osteoporosis; Parkinson Disease; Psychomotor Performance; Quality of Life; Sedentary Behavior; Sleep Wake Disorders

2011
[Pathological gambling behavior in a patient with Parkinson's disease treated with levodopa and bromocriptine].
    Revue neurologique, 2003, Volume: 159, Issue:4

    Topics: Antidepressive Agents; Antiparkinson Agents; Bromocriptine; Citalopram; Depressive Disorder; Dopamine Agents; Female; Fluoxetine; Gambling; Humans; Levodopa; Middle Aged; Parkinson Disease

2003
[Parkinson's disease].
    Ryoikibetsu shokogun shirizu, 2003, Issue:40

    Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Cognition Disorders; Depressive Disorder; Humans; Levodopa; Monoamine Oxidase Inhibitors; Parkinson Disease; Risk Factors; Selective Serotonin Reuptake Inhibitors

2003
Managing patients with Parkinson's disease.
    The Practitioner, 2007, Volume: 251, Issue:1694

    Topics: Antiparkinson Agents; Depressive Disorder; Disease Progression; Dopamine Agonists; Humans; Levodopa; Parkinson Disease; Patient Care Planning; Selective Serotonin Reuptake Inhibitors

2007
[Neuroendocrinology of depressive disorders].
    La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris, 1982, Dec-02, Volume: 58, Issue:44

    Topics: Adrenocorticotropic Hormone; Depressive Disorder; Dexamethasone; Dextroamphetamine; Growth Hormone; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Levodopa; Melatonin; Periodicity; Prolactin; Thyrotropin; Thyrotropin-Releasing Hormone

1982
[Neuropsychological aspects in idiopathic Parkinson disease].
    Fortschritte der Neurologie-Psychiatrie, 1995, Volume: 63, Issue:2

    Topics: Aged; Brain Damage, Chronic; Dementia; Depressive Disorder; Humans; Levodopa; Neuropsychological Tests

1995
Critical review of data supporting affective disorder caused by nonpsychotropic medication.
    Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists, 1993, Volume: 5, Issue:4

    Topics: Anti-Bacterial Agents; Anticonvulsants; Antihypertensive Agents; Bipolar Disorder; Depressive Disorder; Drug-Related Side Effects and Adverse Reactions; Glucocorticoids; Histamine H2 Antagonists; Humans; Levodopa

1993
[Depression in Parkinson disease. Clinical and etiopathogenic aspects].
    Annales de medecine interne, 1994, Volume: 145, Issue:4

    Topics: Depressive Disorder; Humans; Levodopa; Parkinson Disease

1994
[Drug treatment of frequent disorders in patients with Parkinson's disease].
    Neurologia (Barcelona, Spain), 1996, Volume: 11, Issue:3

    Topics: Anticonvulsants; Antidepressive Agents; Antihypertensive Agents; Antipsychotic Agents; Calcium Channel Blockers; Depressive Disorder; Humans; Levodopa; Parkinson Disease; Parkinson Disease, Secondary; Tranquilizing Agents

1996
Amine precursor amino acid therapy: from neurochemical basis to clinical aspects.
    Neurochemical research, 1996, Volume: 21, Issue:2

    Topics: 5-Hydroxytryptophan; Amino Acids; Animals; Depressive Disorder; Droxidopa; Histidine; Humans; Levodopa; Parkinson Disease

1996
[From Parkinson's disease to Lewy body disease].
    Presse medicale (Paris, France : 1983), 1992, Apr-18, Volume: 21, Issue:15

    Topics: Alzheimer Disease; Dementia; Depressive Disorder; Humans; Levodopa; Lewy Bodies; Parkinson Disease

1992
Depression and serotonin metabolism: rationale for neurotransmitter precursor treatment.
    Journal of clinical psychopharmacology, 1985, Volume: 5, Issue:4

    Topics: 5-Hydroxytryptophan; Antidepressive Agents, Tricyclic; Blood Platelets; Brain Chemistry; Depressive Disorder; Female; Humans; Hydrocortisone; Hydroxyindoleacetic Acid; Levodopa; Male; Neurotransmitter Agents; Norepinephrine; Receptors, Neurotransmitter; Serotonin; Thyrotropin; Thyrotropin-Releasing Hormone; Tryptophan

1985
Psychiatric disorders in parkinsonism. 1. Functional illnesses and personality.
    Psychosomatics, 1986, Volume: 27, Issue:2

    Topics: Antidepressive Agents; Clozapine; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Female; Homovanillic Acid; Humans; Levodopa; Male; Mental Disorders; Nomifensine; Nortriptyline; Parkinson Disease; Personality; Psychotic Disorders; Serotonin; Tryptophan

1986

Trials

5 trial(s) available for levodopa and Depressive Disorder

ArticleYear
Fluctuating functions related to quality of life in advanced Parkinson disease: effects of duodenal levodopa infusion.
    Acta neurologica Scandinavica, 2008, Volume: 118, Issue:6

    Topics: Aged; Antiparkinson Agents; Cross-Over Studies; Depressive Disorder; Disease Progression; Duodenum; Female; Gait Disorders, Neurologic; Humans; Hyperkinesis; Levodopa; Longitudinal Studies; Male; Middle Aged; Motor Activity; Movement Disorders; Parkinson Disease; Patient Satisfaction; Quality of Life; Sickness Impact Profile; Surveys and Questionnaires; Treatment Outcome

2008
Motor changes during sertraline treatment in depressed patients with Parkinson's disease*.
    European journal of neurology, 2008, Volume: 15, Issue:9

    Topics: Aged; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Cohort Studies; Depression; Depressive Disorder; Dopamine; Drug Interactions; Female; Humans; Levodopa; Male; Middle Aged; Motor Activity; Parkinson Disease; Prospective Studies; Quality of Life; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Severity of Illness Index

2008
Depressive symptoms impacting on health-related quality of life in early Parkinson's disease: results from Chinese L-dopa exposed cohort.
    Clinical neurology and neurosurgery, 2009, Volume: 111, Issue:9

    Topics: Aged; Antiparkinson Agents; China; Cohort Studies; Depressive Disorder; Disease Progression; Double-Blind Method; Female; Ganoderma; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Phytotherapy; Quality of Life; Regression Analysis; Surveys and Questionnaires; Treatment Outcome

2009
Intrastriatal implantation of human retinal pigment epithelial cells attached to microcarriers in advanced Parkinson disease.
    Archives of neurology, 2005, Volume: 62, Issue:12

    Topics: Antiparkinson Agents; Cells, Cultured; Cerebral Hemorrhage; Corpus Striatum; Depressive Disorder; Gelatin; Graft Survival; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Pigment Epithelium of Eye; Pilot Projects; Postoperative Complications; Putamen; Recovery of Function; Stereotaxic Techniques; Treatment Outcome

2005
[Nerve growth factor and the state of serotoninergic system in endogenous depression and mental retardation].
    Vestnik Rossiiskoi akademii meditsinskikh nauk, 1992, Issue:8

    Topics: Adolescent; Adult; Antidepressive Agents, Tricyclic; Blood Platelets; Child; Child, Preschool; Depressive Disorder; Female; Humans; Immunochemistry; In Vitro Techniques; Levodopa; Middle Aged; Nerve Growth Factors; Oxazines; Phenylketonurias; Platelet Aggregation; Receptors, Serotonin; Serotonin; Stimulation, Chemical

1992

Other Studies

63 other study(ies) available for levodopa and Depressive Disorder

ArticleYear
Psychostimulant effect of dopaminergic treatment and addictions in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2017, Volume: 32, Issue:11

    Topics: Aged; Behavior, Addictive; Central Nervous System Stimulants; Depressive Disorder; Dopamine Agents; Dyskinesia, Drug-Induced; Euphoria; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prospective Studies; Substance-Related Disorders

2017
Vascular risk factors and depression in Parkinson's disease.
    European journal of neurology, 2018, Volume: 25, Issue:4

    Topics: Aged; Alcohol Drinking; Antiparkinson Agents; Anxiety; Asian People; Cohort Studies; Cross-Sectional Studies; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Obesity; Overweight; Parkinson Disease; Psychiatric Status Rating Scales; Risk Factors; Sex Factors; Vascular Diseases

2018
The relationship between temperament and depression in Parkinson's disease patients under dopaminergic treatment.
    Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society, 2019, Volume: 19, Issue:1

    Topics: Aged; Antiparkinson Agents; Depressive Disorder; Dopamine Agonists; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Severity of Illness Index; Surveys and Questionnaires; Temperament

2019
Clinical characteristics and quality of life in Chinese patients with multiple system atrophy.
    Brain and behavior, 2018, Volume: 8, Issue:12

    Topics: Antiparkinson Agents; Anxiety Disorders; Asian People; China; Cognitive Dysfunction; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Quality of Life

2018
Patients' expectations of deep brain stimulation, and subjective perceived outcome related to clinical measures in Parkinson's disease: a mixed-method approach.
    Journal of neurology, neurosurgery, and psychiatry, 2013, Volume: 84, Issue:11

    Topics: Adult; Aged; Antiparkinson Agents; Apathy; Culture; Deep Brain Stimulation; Depressive Disorder; Disability Evaluation; Female; Humans; Illness Behavior; Levodopa; Male; Middle Aged; Parkinson Disease; Patient Satisfaction; Patient Selection; Prospective Studies; Quality of Life; Subthalamic Nucleus; Symptom Assessment; Treatment Outcome

2013
Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease.
    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2015, Volume: 36, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Depression; Depressive Disorder; Fatigue; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Quality of Life; Severity of Illness Index; Sleep Wake Disorders; Surveys and Questionnaires

2015
Changes in artistic style and behaviour in Parkinson's disease: dopamine and creativity.
    Journal of neurology, 2009, Volume: 256, Issue:5

    Topics: Antiparkinson Agents; Arm; Art; Benzothiazoles; Brain; Cabergoline; Creativity; Depressive Disorder; Dopamine; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ergolines; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Motor Skills; Obsessive Behavior; Paintings; Parkinson Disease; Pramipexole

2009
Levodopa-induced dyskinesias in spinocerebellar ataxia type 2.
    Archives of neurology, 2010, Volume: 67, Issue:1

    Topics: Antiparkinson Agents; Atrophy; Depressive Disorder; Dose-Response Relationship, Drug; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Rhombencephalon; Spinocerebellar Ataxias

2010
Familial paroxysmal exercise-induced dystonia: atypical presentation of autosomal dominant GTP-cyclohydrolase 1 deficiency.
    Developmental medicine and child neurology, 2010, Volume: 52, Issue:6

    Topics: Adult; Age of Onset; Aged; Antiparkinson Agents; Child; Codon, Nonsense; Depressive Disorder; Dystonia; Exercise; Exons; Family; Female; GTP Cyclohydrolase; Humans; Levodopa; Male; Parkinsonian Disorders; Pedigree; Restless Legs Syndrome

2010
Serotonergic neurotransmission in early Parkinson's disease: a pilot study to assess implications for depression in this disorder.
    The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry, 2010, Volume: 11, Issue:6

    Topics: Aged; Depressive Disorder; Dopamine Plasma Membrane Transport Proteins; Evoked Potentials, Auditory; Female; Humans; Levodopa; Male; Membrane Transport Proteins; Middle Aged; Parkinson Disease; Pilot Projects; Receptors, Serotonin; Serotonin; Synaptic Transmission; Tomography, Emission-Computed, Single-Photon

2010
Psychiatric symptoms screening in the early stages of Parkinson's disease.
    Journal of neurology, 2012, Volume: 259, Issue:1

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Anxiety; Cognition; Depressive Disorder; Diagnostic and Statistical Manual of Mental Disorders; Female; Humans; Levodopa; Male; Mental Disorders; Neuropsychological Tests; Obsessive-Compulsive Disorder; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Psychotic Disorders; Surveys and Questionnaires

2012
Successful subthalamic stimulation in genetic Parkinson's disease caused by duplication of the α-synuclein gene.
    Journal of neurology, 2012, Volume: 259, Issue:1

    Topics: Adult; alpha-Synuclein; Antiparkinson Agents; Deep Brain Stimulation; Depressive Disorder; Dystonia; Executive Function; Female; Follow-Up Studies; Functional Laterality; Gene Duplication; Humans; Levodopa; Neuropsychological Tests; Neurosurgical Procedures; Parkinson Disease; Subthalamic Nucleus; Treatment Outcome

2012
[Extrapyramidal symptoms due to calcinosis cerebri in a patient with unknown primary hypoparathyroidism].
    Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 2012, Volume: 59, Issue:1

    Topics: Basal Ganglia Diseases; Brain Diseases, Metabolic; Calcinosis; Calcitriol; Calcium; Cognition Disorders; Depressive Disorder; Diagnosis, Differential; Dyslipidemias; Female; Gait Disorders, Neurologic; Gluconates; Humans; Hypoparathyroidism; Levodopa; Magnesium; Middle Aged; Syndrome

2012
[Pseudopheochromocytoma in Parkinson disease and depression].
    Psychiatrische Praxis, 2003, Volume: 30 Suppl 2

    Topics: Adrenal Gland Neoplasms; Antidepressive Agents; Antiparkinson Agents; Catecholamines; Depressive Disorder; Diagnosis, Differential; Dopamine Agonists; Drug Therapy, Combination; Female; Flushing; Homovanillic Acid; Humans; Hypertension; Indoles; Levodopa; Middle Aged; Parkinson Disease; Pheochromocytoma; Vanilmandelic Acid

2003
Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease.
    Parkinsonism & related disorders, 2006, Volume: 12, Issue:7

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Comorbidity; Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychotic Disorders

2006
Effects of levodopa and subthalamic nucleus stimulation on cognitive and affective functioning in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2006, Volume: 21, Issue:10

    Topics: Affect; Antiparkinson Agents; Cerebral Cortex; Cognition; Combined Modality Therapy; Corpus Striatum; Deep Brain Stimulation; Depressive Disorder; Extinction, Psychological; Female; Humans; Levodopa; Male; Middle Aged; Motivation; Neural Pathways; Neurologic Examination; Neuropsychological Tests; Problem Solving; Reversal Learning; Subthalamic Nucleus

2006
Antidepressant use in treatment of psychosis with comorbid depression in Parkinson's disease.
    Progress in neuro-psychopharmacology & biological psychiatry, 2007, Jan-30, Volume: 31, Issue:1

    Topics: Affect; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Antipsychotic Agents; Clomipramine; Clozapine; Delusions; Depressive Disorder; Hallucinations; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders

2007
Differential effects of L-dopa and subthalamic stimulation on depressive symptoms and hedonic tone in Parkinson's disease.
    The Journal of neuropsychiatry and clinical neurosciences, 2006,Summer, Volume: 18, Issue:3

    Topics: Affect; Antiparkinson Agents; Cognition; Deep Brain Stimulation; Depressive Disorder; Electrodes, Implanted; Female; Humans; Levodopa; Male; Middle Aged; Movement; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales; Psychomotor Performance; Subthalamic Nucleus

2006
Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
    Movement disorders : official journal of the Movement Disorder Society, 2008, Volume: 23, Issue:1

    Topics: Adult; Antiparkinson Agents; Demography; Depressive Disorder; Disorders of Excessive Somnolence; Dyskinesias; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Polysomnography; Risk Factors; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires

2008
Clinical heterogeneity in newly diagnosed Parkinson's disease.
    Journal of neurology, 2008, Volume: 255, Issue:5

    Topics: Adult; Age Distribution; Age of Onset; Aged; Aged, 80 and over; Anxiety Disorders; Cluster Analysis; Cohort Studies; Comorbidity; Depressive Disorder; Disability Evaluation; Disease Progression; Female; Humans; Immunity, Innate; Levodopa; Male; Middle Aged; Movement Disorders; Netherlands; Neuropsychological Tests; Parkinson Disease; Prospective Studies; Quality of Life

2008
The assessment of post-detoxification anhedonia: influence of clinical and psychosocial variables.
    Substance use & misuse, 2008, Volume: 43, Issue:5

    Topics: Adolescent; Adult; Affective Symptoms; Alcoholism; Comorbidity; Depressive Disorder; Europe; Female; Humans; Levodopa; Male; Middle Aged; Opioid-Related Disorders; Predictive Value of Tests; Psychiatric Status Rating Scales; Psychometrics; Regression Analysis; Severity of Illness Index; Substance-Related Disorders

2008
Coexistence of severe parkinsonism and tardive dyskinesia as side effects of neuroleptic therapy.
    The Journal of clinical psychiatry, 1984, Volume: 45, Issue:1

    Topics: Aged; Antipsychotic Agents; Carbidopa; Corpus Striatum; Depressive Disorder; Drug Combinations; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Metoclopramide; Parkinson Disease, Secondary; Receptors, Dopamine

1984
Animal models used in prediction of antidepressant effects in man.
    The Journal of clinical psychiatry, 1983, Volume: 44, Issue:5 Pt 2

    Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Depressive Disorder; Drug Evaluation, Preclinical; Drug Synergism; Helplessness, Learned; Humans; Levodopa; Mice; Models, Biological; Motor Activity; Propiophenones; Rats; Reserpine; Tetrabenazine

1983
[Parkinson's disease and neurotransmitters].
    Nihon rinsho. Japanese journal of clinical medicine, 1984, Volume: 42, Issue:4

    Topics: Aged; Depressive Disorder; Dopamine; Humans; Levodopa; Parkinson Disease

1984
Prolactin and growth hormone response to levodopa in affective illness.
    Neuropsychobiology, 1983, Volume: 9, Issue:2-3

    Topics: Amitriptyline; Bipolar Disorder; Depressive Disorder; Female; Growth Hormone; Humans; Hypothalamo-Hypophyseal System; Levodopa; Menopause; Prolactin

1983
Depression and Parkinson's disease.
    Advances in neurology, 1984, Volume: 40

    Topics: Depressive Disorder; Diagnosis, Differential; Humans; Levodopa; Parkinson Disease; Personality Assessment

1984
Mental disorders in Parkinson's disease after treatment with L-DOPA.
    Advances in neurology, 1984, Volume: 40

    Topics: Aged; Anxiety Disorders; Confusion; Delirium; Dementia; Depressive Disorder; Female; Hallucinations; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Parkinson Disease

1984
Pyridoxine and depression: neuroendocrine aspects.
    Acta vitaminologica et enzymologica, 1982, Volume: 4, Issue:1-2

    Topics: Depressive Disorder; Dopamine; Drug Synergism; Drug Therapy, Combination; Humans; Levodopa; Male; Prolactin; Pyridoxine; Thyrotropin-Releasing Hormone

1982
Behavioral alterations and the therapy of parkinsonism.
    Clinical neuropharmacology, 1982, Volume: 5 Suppl 1

    Topics: Bipolar Disorder; Bromocriptine; Dementia; Depressive Disorder; Humans; Levodopa; Mental Processes; Parkinson Disease; Psychoses, Substance-Induced

1982
[Various factors common to the pathogenesis of endogenous depression and chronic alcoholism].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1981, Volume: 81, Issue:9

    Topics: 11-Hydroxycorticosteroids; Adolescent; Adult; Aged; Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Benzodiazepinones; Depressive Disorder; Dexamethasone; Female; Humans; Levodopa; Male; Mental Disorders; Middle Aged; Tryptophan

1981
Anticholinergic effects in a depressed parkinsonian patient.
    Journal of geriatric psychiatry and neurology, 1995, Volume: 8, Issue:2

    Topics: Aged; Benztropine; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Male; Parkinson Disease; Treatment Outcome

1995
Which factors predict cognitive decline in Parkinson's disease?
    Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:1

    Topics: Activities of Daily Living; Age of Onset; Aged; Cognition Disorders; Depressive Disorder; Educational Status; Humans; Levodopa; Middle Aged; Movement Disorders; Neuropsychological Tests; Parkinson Disease; Prognosis; Severity of Illness Index; Task Performance and Analysis; Tremor

1995
PET studies of presynaptic monoamine metabolism in depressed patients and healthy volunteers.
    Pharmacopsychiatry, 1994, Volume: 27, Issue:1

    Topics: 5-Hydroxytryptophan; Animals; Brain; Depressive Disorder; Humans; Levodopa; Presynaptic Terminals; Tomography, Emission-Computed

1994
Value and appropriate use of rating scales and apparative measurements in quantification of disability in Parkinson's disease.
    Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 5, Issue:1

    Topics: Aged; Dementia; Depression; Depressive Disorder; Disability Evaluation; Female; Humans; Hypotension, Orthostatic; Levodopa; Male; Parkinson Disease; Psychomotor Performance; Reference Values; Tremor

1993
Serotonin and Parkinson's disease.
    The American journal of psychiatry, 1993, Volume: 150, Issue:5

    Topics: Basal Ganglia Diseases; Depressive Disorder; Dopamine; Drug Therapy, Combination; Fluoxetine; Humans; Levodopa; Parkinson Disease; Serotonin; Tryptophan

1993
Hypothesis: the bradyphrenia of parkinsonism is a nosological entity.
    Acta neurologica Scandinavica, 1993, Volume: 87, Issue:4

    Topics: Adult; Aged; Aging; Alcohol Drinking; Antiparkinson Agents; Cognition; Cognition Disorders; Depressive Disorder; Ethanol; Female; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease; Probability; Psychological Tests; Reaction Time

1993
Familial akathisia and depression treated with nefazodone.
    Canadian journal of psychiatry. Revue canadienne de psychiatrie, 1996, Volume: 41, Issue:8

    Topics: Adult; Akathisia, Drug-Induced; Antidepressive Agents, Second-Generation; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Piperazines; Restless Legs Syndrome; Selective Serotonin Reuptake Inhibitors; Triazoles

1996
Plasma HVA and MHPG in psychiatric patients with renal failure and levodopa-treated Parkinson's disease.
    The Journal of neuropsychiatry and clinical neurosciences, 1996,Fall, Volume: 8, Issue:4

    Topics: Adult; Aged; Depressive Disorder; Female; Homovanillic Acid; Humans; Kidney Failure, Chronic; Levodopa; Male; Mental Disorders; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Psychotic Disorders; Renal Dialysis

1996
[Depressive pseudodementia in early Parkinson's disease: lessons from a case with long-term follow-up].
    Neurologia (Barcelona, Spain), 1997, Volume: 12, Issue:3

    Topics: Aged; Dementia; Depressive Disorder; Female; Humans; Levodopa; Neuropsychological Tests; Parkinson Disease; Psychiatric Status Rating Scales

1997
Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Pharmacopsychiatry, 1997, Volume: 30, Issue:6

    Topics: Adult; Antidepressive Agents, Tricyclic; Antiparkinson Agents; Depressive Disorder; Drug Interactions; Female; Humans; Levodopa; Mianserin; Mirtazapine; Parkinson Disease; Psychoses, Substance-Induced; Suicide, Attempted

1997
The effect of long-term levodopa therapy on depression level in de novo patients with Parkinson's disease.
    Journal of the neurological sciences, 2000, Jan-01, Volume: 172, Issue:1

    Topics: Depressive Disorder; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Psychiatric Status Rating Scales; Time Factors

2000
[Parkinson's disease].
    Presse medicale (Paris, France : 1983), 2001, Mar-03, Volume: 30, Issue:8

    Topics: Adult; Age Factors; Aged; Antiparkinson Agents; Catechols; Depressive Disorder; Diagnosis, Differential; Dopamine Agents; Dopamine Agonists; Follow-Up Studies; Humans; Indoles; Levodopa; Lewy Body Disease; Neuroprotective Agents; Nitriles; Parkinson Disease; Parkinsonian Disorders; Pergolide; Psychiatric Status Rating Scales; Psychotic Disorders; Time Factors

2001
Some neuroendocrine parameters in bipolar and unipolar depression.
    Journal of affective disorders, 1979, Volume: 1, Issue:1

    Topics: Adult; Bipolar Disorder; Depressive Disorder; Dopamine beta-Hydroxylase; Female; Growth Hormone; Humans; Levodopa; Middle Aged; Prolactin

1979
Phenelzine treatment of depression in Parkinson's disease.
    The American journal of psychiatry, 1992, Volume: 149, Issue:12

    Topics: Aged; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Parkinson Disease; Phenelzine

1992
ECT and delirium in Parkinson's disease.
    The American journal of psychiatry, 1992, Volume: 149, Issue:12

    Topics: Carbidopa; Combined Modality Therapy; Delirium; Depressive Disorder; Drug Combinations; Electroconvulsive Therapy; Humans; Levodopa; Parkinson Disease

1992
Unforeseen beneficial effects of controlled-release levodopa-carbidopa (Sinemet CR)
    The Journal of neuropsychiatry and clinical neurosciences, 1992,Spring, Volume: 4, Issue:2

    Topics: Aged; Antiparkinson Agents; Carbidopa; Delayed-Action Preparations; Depressive Disorder; Drug Administration Schedule; Drug Combinations; Humans; Levodopa; Male; Neurologic Examination; Parkinson Disease

1992
The effect of R-(-)-deprenyl in de novo parkinsonian patients pretreated with levodopa and decarboxylase inhibitor correlated to depression and MHPS, HIAA, and HVA levels of cerebrospinal fluid.
    Advances in neurology, 1990, Volume: 53

    Topics: Carboxy-Lyases; Depressive Disorder; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Male; Methoxyhydroxyphenylglycol; Middle Aged; Motor Skills; Neurologic Examination; Parkinson Disease; Selegiline

1990
Growth hormone dysregulation in children with major depressive disorder.
    Journal of the American Academy of Child and Adolescent Psychiatry, 1990, Volume: 29, Issue:2

    Topics: Brain; Child; Clonidine; Depressive Disorder; Growth Hormone; Humans; Levodopa; Receptors, Adrenergic, alpha; Receptors, Dopamine

1990
Neuroleptic malignant syndrome without neuroleptics.
    Journal of clinical psychopharmacology, 1990, Volume: 10, Issue:6

    Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Female; Humans; Levodopa; Neuroleptic Malignant Syndrome; Parkinson Disease; Substance Withdrawal Syndrome; Tranylcypromine; Tryptophan

1990
Clinical and biochemical features of depression in Parkinson's disease.
    The American journal of psychiatry, 1986, Volume: 143, Issue:6

    Topics: Aged; Depressive Disorder; Dexamethasone; Growth Hormone; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Levodopa; Methoxyhydroxyphenylglycol; Middle Aged; Parkinson Disease; Prolactin; Psychomotor Performance; Self Concept; Thyrotropin-Releasing Hormone

1986
Parkinsonism manifesting depression as the first sign.
    The Japanese journal of psychiatry and neurology, 1989, Volume: 43, Issue:1

    Topics: Aged; Antidepressive Agents; Depressive Disorder; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease

1989
ECT and Parkinson's disease revisited: a "naturalistic" study.
    The American journal of psychiatry, 1989, Volume: 146, Issue:11

    Topics: Aged; Carbidopa; Confusion; Depressive Disorder; Electroconvulsive Therapy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Receptors, Dopamine

1989
Determination of plasma pyridoxal 5'-phosphate by an enzymatic-high-performance liquid chromatographic procedure.
    Analytical biochemistry, 1989, Volume: 181, Issue:2

    Topics: Chromatography, High Pressure Liquid; Depressive Disorder; Diet; Humans; Levodopa; Phenelzine; Pyridoxal Phosphate; Streptococcus

1989
A therapeutic approach to tardive dyskinesia.
    The Journal of clinical psychiatry, 1985, Volume: 46, Issue:4 Pt 2

    Topics: Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Colitis; Depressive Disorder; Dyskinesia, Drug-Induced; Female; Humans; Levodopa; Male; Methyltyrosines; Middle Aged; Nausea; Paranoid Disorders; Psychomotor Agitation; Psychoses, Substance-Induced; Psychotic Disorders; Receptors, Dopamine; Reserpine; Tetrabenazine; Time Factors

1985
[Depression and Parkinson syndrome].
    Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16

    Topics: Antidepressive Agents; Brain; Depressive Disorder; Drug Therapy, Combination; Humans; Levodopa; Neurotransmitter Agents; Parkinson Disease; Tryptophan

1986
Changes in serum prolactin after electroconvulsive and epileptic seizures.
    European archives of psychiatry and neurological sciences, 1987, Volume: 236, Issue:5

    Topics: Adult; Antipsychotic Agents; Depressive Disorder; Dopamine; Electroconvulsive Therapy; Epilepsy; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Prolactin; Schizophrenia

1987
Parkinson's disease, depression, and the on-off phenomenon.
    Psychosomatics, 1989,Winter, Volume: 30, Issue:1

    Topics: Bromocriptine; Carbidopa; Depressive Disorder; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Male; Middle Aged; Motor Skills; Parkinson Disease

1989
[Therapeutic strategies and tactics in parkinsonism].
    Wiener medizinische Wochenschrift (1946), 1986, Aug-31, Volume: 136, Issue:15-16

    Topics: Amantadine; Antidepressive Agents; Antiparkinson Agents; Benserazide; Carbidopa; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Combinations; Drug Therapy, Combination; Humans; Levodopa; Lisuride; Motor Skills; Parkinson Disease; Selegiline; Sleep Initiation and Maintenance Disorders

1986
L-5-hydroxytryptophan alone and in combination with a peripheral decarboxylase inhibitor in the treatment of depression.
    Neuropsychobiology, 1988, Volume: 20, Issue:1

    Topics: 5-Hydroxytryptophan; Adult; Aged; Benserazide; Bipolar Disorder; Depressive Disorder; Dose-Response Relationship, Drug; Drug Combinations; Drug Therapy, Combination; Female; Humans; Hydrazines; Levodopa; Male; Middle Aged; Psychological Tests; Retrospective Studies

1988
Mood swings associated with the 'on-off' phenomenon in Parkinson's disease.
    Psychological medicine, 1987, Volume: 17, Issue:4

    Topics: Adult; Aged; Antiparkinson Agents; Carbidopa; Depressive Disorder; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Mood Disorders; Parkinson Disease; Parkinson Disease, Secondary

1987
Response of tardive and L-dopa-induced dyskinesias to antidepressants.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1987, Volume: 14, Issue:4

    Topics: Aged; Antidepressive Agents; Depressive Disorder; Desipramine; Dyskinesia, Drug-Induced; Humans; Levodopa; Male; Middle Aged; Parkinson Disease, Secondary; Trazodone

1987
Dexamethasone suppression test in Parkinson's disease.
    Advances in neurology, 1987, Volume: 45

    Topics: Aged; Depressive Disorder; Dexamethasone; Female; Humans; Hydrocortisone; Levodopa; Male; Parkinson Disease

1987
Major depression and carbon monoxide-induced parkinsonism: diagnosis, computerized axial tomography, and response to L-dopa.
    The Journal of nervous and mental disease, 1985, Volume: 173, Issue:8

    Topics: Adult; Antidepressive Agents, Tricyclic; Carbon Monoxide Poisoning; Depressive Disorder; Globus Pallidus; Humans; Levodopa; Male; Necrosis; Parkinson Disease, Secondary; Tomography, X-Ray Computed

1985